ACE2 and Ang-(1–7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response

Inflammation Research

Volumn 64, Issue 3-4, 2015, Pages 253-260

  Zhang, Yue Hui ^a,c,e   Zhang, Yong huan ^a,b   Dong, Xue Fei ^d,e   Hao, Qing Qing ^a,b   Zhou, Xiao Ming ^a   Yu, Qing Tao ^a   Li, Shu Ying ^a   Chen, Xu ^a,b   Tengbeh, Abdulai Fallah ^a   Dong, Bo ^a,e   Zhang, Yun ^e  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Department of Cardiology   (China)

^d HEBEI MEDICAL UNIVERSITY   (China)

^e SHANDONG UNIVERSITY   (China)

Author keywords

Ang (1 7); Angiotensin converting enzyme 2; Atherosclerosis; Endothelial function; Gene therapy; Inflammation

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; APOLIPOPROTEIN E; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPEROXIDE DISMUTASE; VASCULAR CELL ADHESION MOLECULE 1; ANGIOTENSIN I; ANGIOTENSIN I (1-7); ANGIOTENSIN II; CCL2 PROTEIN, HUMAN; CCL2 PROTEIN, MOUSE; DIPEPTIDYL CARBOXYPEPTIDASE; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANIMAL; CELL MOTION; CYTOLOGY; DEFICIENCY; DISEASE MODEL; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL ADHESION; CELL MOVEMENT; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; E-SELECTIN; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; HUMANS; IN VITRO TECHNIQUES; INFLAMMATION; MICE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; SIGNAL TRANSDUCTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84925486259     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-015-0805-1     Document Type: Article

References (23)

1. Wang Y, Tikellis C, Thomas MC, Golledge J. Angiotensin converting enzyme 2 and atherosclerosis. Atherosclerosis. 2013;226:3–8.
2. Zhao W, Zhao T, Chen Y, Sun Y. Angiotensin 1–7 promotes cardiac angiogenesis following infarction. Curr Vasc Pharmacol. 2013;29. [Epub ahead of print].
3. Dong B, Yu QT, Dai HY, Gao YY, Zhou ZL, Zhang L, Jiang H, Gao F, Li SY, Zhang YH, Bian HJ, Liu CX, Wang N, Xu H, Pan CM, Song HD, Zhang C, Zhang Y. Angiotensin converting enzyme 2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. J Am Coll Cardiol. 2012;9:739–47.
4. Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, Thorn L, Sandholm N, Thomas MC, Groop PH. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens. 2012;30:375–83.
5. Su Z, Zimpelmann J, Burns KD. Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 2006;69:2212–8.
6. Kanda T, Itoh H. The ACE2/Ang(1–7)/Mas receptor axis in cardiovascular and renal diseases. Nihon Rinsho. 2012;70:1487–91.
7. Xu P, Sriramula S, Lazartigues E. ACE2/Ang-(1–7)/Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol. 2011;300:R804–17.
8. Tikellis C, Bernardi S, Burns WC. Angiotensin converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Curr Opin Nephrol Hypertens. 2011;20:62–8.
9. Dong B, Zhang C, Feng JB, Zhao YX, Li SY, Yang YP, Dong QL, Deng BP, Zhu L, Yu QT, Liu CX, Liu B, Pan CM, Song HD, Zhang MX, Zhang Y. Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:1270–6.
10. Zhang W, Miao J, Wang S, Zhang Y. The protective effects of beta-casomorphin-7against glucose-inducedrenaloxidativestress in vivo and vitro. PLoS One. 2013;8(5):e63472.
11. Barton M. Prevention and endothelial therapy of coronary artery disease. Curr Opin Pharmacol. 2013;13:226–41.
12. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab. 2007;18:208–14.
13. Singh VP, Le B, Khode R, Baker KM, Kumar R. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes. 2008;57:3297–306.
14. Twigg MW, Freestone K, Homer S, Ponnambalam S. The LOX-1 scavenger receptor and its implications in the treatment of vascular disease. Cardiol Res Pract. 2012;632:408.
15. Pirillo A, Reduzzi A, Ferri N, Kuhn H, Corsini A, Catapano AL. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells. Atherosclerosis. 2011;214:331–7.
16. Balın M, Celik A, Kobat MA. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease. Clin Res Cardiol. 2012;101:247–53.
17. Chae YJ, Kim CH, Ha TS, Hescheler J, Ahn HY, Sachinidis A. Epigallocatechin-3-O-gallate inhibits the angiotensin II-induced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways. Cell Physiol Biochem. 2007;20(6):859–66.
18. Feng Y, Hans C, McIlwain E, Varner KJ, Lazartigues E. Angiotensinconverting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy. PLoS One. 2012;7:e48910.
19. Pei Z, Meng R, Li G, Yan G, Xu C, Zhuang Z, Ren J, Wu Z. Angiotensin-(1–7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs/TIMPs. Toxicol Lett. 2010;199:173–81.
20. Johnson JA, West J, Maynard KB, Hemnes AR. ACE2 improves right ventricular function in a pressure overload model. PLoS One. 2011;6:e20828.
21. Lovren F, Pan Y, Quan A, Teoh H, Wang G, Shukla PC, Levitt KS, Oudit GY, Al-Omran M, Stewart DJ, Slutsky AS, Peterson MD, Backx PH, Penninger JM, Verma S. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol Heart Circ Physiol. 2011;295:H1377–84.
22. Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE. Vasoprotective and atheroprotective effects of angiotensin (1–7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2010;30:1606–13.
23. Sampaio WO, dos Santos RAS, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007;49:185–92.